Enfusion

Enfusion Rule of 40

Delisted

The Rule of 40 of Enfusion (ENFN) as of Nov 7, 2026 is 18.57 %. In the previous year, Rule of 40 was 22.93 % — a change of -19.04% (lower).

Rule of 40

18.57 %

YoY

-19.04%

Last updated:

Rule of 40 of Enfusion is 2024 18.57 % . Rule of 40 of Enfusion was 2023 22.93 % . It decreases by -19.04% lower compared to the previous year.

The Enfusion Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2020
42.43 USD
Jan 1, 2021
-207.66 USD
Jan 1, 2022
26.64 USD
Jan 1, 2023
22.93 USD
Jan 1, 2024
18.57 USD
The Enfusion Rule of 40 history
YEARRule of 40YoY
18.57 %-19.04%
22.93 %-13.93%
26.64 %-112.83%
-207.66 %-589.44%
42.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Rule of 40 of Enfusion is 18.57 % in 2024.

On Eulerpool you can find the complete historical development of Rule of 40 Enfusion since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Enfusion

All Key Metrics — Enfusion